To our knowledge, this is the first report of [225Ac]Ac-FAPI-46 RLT in a fully immunocompetent mouse model of fibrosarcoma with stable and homogenous expression of murine FAP, allowing the study of FAP-RLT and its combination with immunotherapeutic approaches. This evidence concerns the gene FAP and fibrosarcoma.